Clover Health Corp's stock price fell sharply during intraday trading, plummeting 5.09% as investor sentiment turned negative following an analyst rating announcement.
The decline came after Leerink Partners maintained its "Market Perform" rating on Clover Health Investments, suggesting the stock is expected to perform in line with the broader market rather than outperform. This neutral stance may have disappointed investors who were anticipating a more bullish outlook from analysts.